Overview

Study of Bupropion Versus Bupropion + Naltrexone for Smoking Cessation

Status:
Unknown status
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the effects of bupropion + placebo to bupropion + naltrexone as treatments to help smokers quit.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
University of Minnesota
University of Minnesota - Clinical and Translational Science Institute
Collaborator:
National Institute on Drug Abuse (NIDA)
Treatments:
Bupropion
Naltrexone